BusinessDermira to Present Data from DRM04 Phase 3 Clinical Trials at Late-Breaking News Session at European Academy of Dermatology and Venereology CongressBy Nasdaq OMXSep 28, 2016, 11:30 AM UTC
BusinessDermira Completes Patient Enrollment for Third CIMZIA® (certolizumab pegol) Phase 3 Clinical Trial in Psoriasis Program and Updates Guidance for Release of Topline DataBy Nasdaq OMXJan 8, 2016, 6:00 AM UTC